Concepedia

Hans‐Peter Gerber

HG

Statistics

Publications

60

Citations

13.7K

H-Index

47

Active since

1994

Affiliations

Molecular Oncology (United States)(Current)

Pfizer (United States)

Seagen (United States)

Pearl River Community College

University of California San Diego

Hans‐Peter Gerber is an author at Molecular Oncology (United States) specializing in medicine, angiogenesis, and oncology.

ORCID

Publications per year

1994–2022

60

Publications

60

Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells

Hans‐Peter Gerber, Vishva M. Dixit, Napoleone Ferrara · Journal of Biological Chemistry · 1998 · 990 citations · Full text

, , +16

VEGF is required for growth and survival in neonatal mice

Hans‐Peter Gerber, Kenneth J. Hillan, Anne Ryan et al. · Development · 1999 · 918 citations · Full text

, , +16

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

Farbod Shojaei, Xiumin Wu, Ajay K. Malik et al. · Nature Biotechnology · 2007 · 840 citations

, , +13

Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes

Hans‐Peter Gerber, Fabrizio Condorelli, Jeanie Park et al. · Journal of Biological Chemistry · 1997 · 795 citations · Full text

, , +15

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

Hans‐Peter Gerber, Ajay K. Malik, Gregg P. Solar et al. · Nature · 2002 · 706 citations

, , +12

1–5 of 60